Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
ImmunoPrecise Antibodies ( (IPA) ) just unveiled an announcement.
ImmunoPrecise Antibodies Ltd. announced that Kristin Taylor, the Chief Financial Officer, will resign effective January 16, 2025, but will stay on as a consultant thereafter. The company has initiated a CFO succession process, highlighting its ongoing commitment to maintaining robust financial planning and operational continuity.
More about ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd. is a biotechnology company specializing in multi-omics modeling and complex artificial intelligence through proprietary technologies. The company offers an integrated suite of capabilities for developing therapeutic antibodies and addresses complex industry challenges, with subsidiaries in North America and Europe.
YTD Price Performance: 0.0%
Average Trading Volume: 553,313
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $13.98M
See more data about IPA stock on TipRanks’ Stock Analysis page.
